- Direct detection of early-stage cancers using circulating tumor DNA.
- Discovery and validation of a colorectal cancer classifier in a new blood test with improved performance for high-risk subjects.
- Clinical implications of monitoring circulating tumor DNA in patients with colorectal cancer.
- Serological biomarkers in triage of FIT-positive subjects?
- Detection of colorectal neoplasia: Combination of eight blood-based, cancer-associated protein biomarkers.
- Increased serological cancer-associated biomarkers and risk of development of primary malignancy after large bowel endoscopy.
- Pre-analytical variables of circulating cell-free nucleosomes containing 5-methylcytosine DNA or histone modification H3K9Me3.
- Protocol Outlines for Parts 1 and 2 of the Prospective Endoscopy III Study for the Early Detection of Colorectal Cancer: Validation of a Concept Based on Blood Biomarkers.
- miRNA profiling of circulating EpCAM(+) extracellular vesicles: promising biomarkers of colorectal cancer.
- Localization of active, dually phosphorylated extracellular signal-regulated kinase 1 and 2 in colorectal cancer with or without activating BRAF and KRAS mutations.
